Evidence map›Paper›PMID 40414211›Full record

ArticleKidney & blood pressure research2025

CFHR5 Nephropathy Case Report: A Novel Variant Characterized by Tubulointerstitial Kidney Disease.

Rita Santarsiere, Giulia Florio, Annalisa Gonnella, Pierluigi D'Angiò, Simona Laurino, Miriam Zacchia, Francesca Del Vecchio Blanco, Alessandra F Perna, Francesco Trepiccione, Giuseppe Gigliotti

Abstract readCase Reports
In one paragraph

Article in Kidney & blood pressure research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rita SantarsiereDepartment of Medical Translational Sciences, University of Campania "L. Vanvitelli", Naples, Italy.
Giulia FlorioDepartment of Medical Translational Sciences, University of Campania "L. Vanvitelli", Naples, Italy, giulia.florio@studenti.unicampania.it.
Annalisa GonnellaNephrology and Dialysis Unit, Maria Santissima Addolorata Hospital, Eboli, Italy.
Pierluigi D'AngiòNephrology and Dialysis Unit, Maria Santissima Addolorata Hospital, Eboli, Italy.
Simona LaurinoNephrology and Dialysis Unit, Maria Santissima Addolorata Hospital, Eboli, Italy.
Miriam ZacchiaDepartment of Medical Translational Sciences, University of Campania "L. Vanvitelli", Naples, Italy.
Francesca Del Vecchio BlancoDepartment of Precision Medicine, University of Campania "L. Vanvitelli", Caserta, Italy.
Alessandra F PernaDepartment of Medical Translational Sciences, University of Campania "L. Vanvitelli", Naples, Italy.
Francesco TrepiccioneDepartment of Medical Translational Sciences, University of Campania "L. Vanvitelli", Naples, Italy.
Giuseppe GigliottiNephrology and Dialysis Unit, Maria Santissima Addolorata Hospital, Eboli, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCFHR5 nephropathy is considered a subtype of C3 glomerulopathy. It was originally described in Greek Cypriot families and it is characterized by the time with the development of microscopic hematuria and proteinuria associated with a fast progression toward ESKD, especially in men. These symptoms present an autosomal dominant inheritance pattern and are associated with the exon 2 to 3 duplication of the CFHR5 gene. CASE PRESENTATION: Here, we describe a novel clinical phenotype associated with a variant of the CFHR5. The affected subjects present the clinical features of autosomal dominant tubulo-interstitial kidney disease. They present with CKD of unknown origin with no hematuria nor proteinuria. Like the classical CFHR5 nephropathy, males have a worse prognosis than females, with a fast progression toward ESKD in the second-third decade of life. Kidney pathology shows severe tubular atrophy and interstitial fibrosis and infiltrate. Arteries involvement is characterized by thickening of the intima layer, while no major alterations are described at the glomerular level. Electron microscopy confirms no interstitial or glomerular filtration barrier alterations.

conclusionThe exact mechanism behind this phenomenon remains unclear; we hope that our case will encourage further investigation.

Indexed as

Kidney DiseasesNephritis, InterstitialComplement System ProteinsHumansCFHR5 protein, humanComplement System ProteinsADTKDADTKD-CFHR5C3 glomerulopathyCFHR5CFHR5 nephropathy

Identifiers

PMID40414211
PMCPMC12187096

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.